VYTRUS BIOTECH EO -01 (V5P) — Free Cash Flow Generation Index
VYTRUS BIOTECH EO -01 (V5P) has a Free Cash Flow Generation Index of 0.31x as of December 2025. Free cash flow of €1.22 Million represents 0% of operating cash flow (€3.90 Million). Explore reinvestment intensity of VYTRUS BIOTECH EO -01 to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
VYTRUS BIOTECH EO -01 Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for VYTRUS BIOTECH EO -01 across 5 annual periods. For the full cash flow conversion analysis, see V5P cash flow metrics.
Annual Free Cash Flow Generation for VYTRUS BIOTECH EO -01 (2021–2025)
Year-by-year Free Cash Flow Generation Index for VYTRUS BIOTECH EO -01. Check V5P cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | €1.22 Million | €3.90 Million | €2.68 Million | ▼ -9.8% |
| 2024 | 0.35x | €640.24K | €1.84 Million | €1.20 Million | ▲ +219.9% |
| 2023 | -0.29x | €-261.83K | €904.39K | €1.17 Million | ▼ -10.6% |
| 2022 | -0.26x | €-268.62K | €1.03 Million | €1.29 Million | ▼ -166.6% |
| 2021 | 0.39x | €176.11K | €447.92K | €271.82K | — |